Founded in 2010, Oncotarget is a medical journal published by Impact Journals and Mikhail Blagosklonny and Andrei V. Gudkov as the chief editors. The open access journal is peer-reviewed weekly and covers comprehensive research on all oncology features. Oncotarget also offers free Altmetric article briefs as part of their latest journal platform to offer synchronized tracking of items coverage in digital and traditional media channels.
The medical journal has published 370 reports on oxygen-related topics since its establishment in 2010. William G. Kaelin, Jr. and Gregg L. Semenza are both members of Oncotarget. The duo won the Lasker Award in 2016 following the discovery of the passageway of detecting oxygen. Oncotarget is a traditional and multidisciplinary journal that provides free access. It publishes reports online on current issues weekly.
The journal works closely with many high profile scientific archives and indexes to ensure experimental results are rapidly and available to medical field practitioners, researchers, and the public as well. To speed up the processing of indexes, Oncotarget is now publishing two subjects a week. After allocating issue and page numbers, they will feature permanently in the PubMed.
Oncotarget medical journal covers research on all issues of oncology and publishes sub-sections on subjects beyond oncology such as Immunology, Microbiology, Pathology, Aging, Autophagy, and Chromosomes among others. It has so far released 324 issues and seven volumes since 2010 and is currently working on its eighth volume. The journal assigns each report published a direct object identifier (DOI) and utilized the recommendations of the Committee on Publication Ethics (COPE) to its entire published works.
Oncotarget publishes all its papers online with a goal to make scientific results widely available fast, to boost the impact of research using an insightful review, and to abolish the gap between the domains of the biomedical field. Oncotarget adopts applications of elementary and clinical science to battle against disease and illnesses.
Under the able leadership of the most famous scientists, the journal assists all researchers to contribute to the growth and development of science. The journal offers opportunities to writers interested in writing on oncology issues. However, the submitted work should be of high quality and also pass all the ethical tests. Oncotarget is committed to working relentlessly to see a life without disease.